From NAFLD in clinical practice to answers from guidelines

被引:305
作者
Nascimbeni, Fabio [1 ]
Pais, Raluca [2 ]
Bellentani, Stefano [3 ]
Day, Christopher Paul [4 ]
Ratziu, Vlad [2 ]
Loria, Paola [1 ]
Lonardo, Amedeo [1 ]
机构
[1] Univ Modena & Reggio Emilia, Modena, Italy
[2] INSERM Salpetriere, Paris, France
[3] Azienda USL, Modena, Italy
[4] Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
关键词
Guidelines; NAFLD; Clinical practice; NONALCOHOLIC FATTY LIVER; GAMMA-GLUTAMYL-TRANSFERASE; ASIA-PACIFIC REGION; TERM-FOLLOW-UP; CRYPTOGENIC CIRRHOSIS; METABOLIC SYNDROME; HEPATIC STEATOSIS; NATURAL-HISTORY; ALCOHOL-CONSUMPTION; RISK-FACTORS;
D O I
10.1016/j.jhep.2013.05.044
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
This review of the literature consists of three sections. First, papers concerning non-alcoholic fatty liver disease (NAFLD) awareness among the general population, general practitioners, and liver and non-liver specialists were retrieved and analyzed to highlight the perception of disease, verify knowledge of current recommendations, and identify the main difficulties experienced in clinical practice. Next, position papers and clinical practice guidelines issued by International and National Hepatological Scientific Societies were identified and critically assessed in order to pinpoint the areas of convergence/difference. Finally, practical suggestions on NAFLD diagnosis and management in daily practice are provided and the open questions highlighted. (C) 2013 European Association for the Study of the Liver. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:859 / 871
页数:13
相关论文
共 136 条
[1]   The natural history of nonalcoholic fatty liver disease: A population-based cohort study [J].
Adams, LA ;
Lymp, JF ;
St Sauver, J ;
Sanderson, SO ;
Lindor, KD ;
Feldstein, A ;
Angulo, P .
GASTROENTEROLOGY, 2005, 129 (01) :113-121
[2]   The metabolic syndrome - a new worldwide definition [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
LANCET, 2005, 366 (9491) :1059-1062
[3]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[4]  
[Anonymous], 1999, DIAGN CLASS DIAB MEL
[5]   Fatty infiltration of liver in hyperlipidemic patients [J].
Assy, N ;
Kaita, K ;
Mymin, D ;
Levy, C ;
Rosser, B ;
Minuk, G .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (10) :1929-1934
[6]   The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study [J].
Azoulay, Laurent ;
Yin, Hui ;
Filion, Kristian B. ;
Assayag, Jonathan ;
Majdan, Agnieszka ;
Pollak, Michael N. ;
Suissa, Samy .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[7]   Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace [J].
Baffy, Gyoergy ;
Brunt, Elizabeth M. ;
Caldwell, Stephen H. .
JOURNAL OF HEPATOLOGY, 2012, 56 (06) :1384-1391
[8]   Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD [J].
Ballestri, Stefano ;
Lonardo, Amedeo ;
Romagnoli, Dante ;
Carulli, Lucia ;
Losi, Luisa ;
Day, Christopher P. ;
Loria, Paola .
LIVER INTERNATIONAL, 2012, 32 (08) :1242-1252
[9]   Impact of fatty liver disease on health care utilization and costs in a general population:: A 5-year observation [J].
Baumeister, Sebastian E. ;
Voelzke, Henry ;
Marschall, Paul ;
John, Ulrich ;
Schmidt, Carsten-Oliver ;
Flessa, Steffen ;
Alte, Dietrich .
GASTROENTEROLOGY, 2008, 134 (01) :85-94
[10]   Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study [J].
Bedogni, G ;
Miglioli, L ;
Masutti, F ;
Tiribelli, C ;
Marchesini, G ;
Bellentani, S .
HEPATOLOGY, 2005, 42 (01) :44-52